Trial intelligence / Profile preview

Emend for Delayed CINV in Autologous Stem Cell Transplantation

NCT01101529Phase 2Completed

Sponsor
Akademiska sjukhuset
Start
May 2010
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Akademiska sjukhuset. Started May 2010; status: completed.

02

Drugs

aprepitant
03

Conditions

chemotherapy-induced nausea and vomiting (CINV)

Beyond the preview

Go deeper on NCT01101529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01101529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call